NANETS' NET Symposium Committee member Sukhmani K. Padda, MD has been selected to direct thoracic medical oncology at Cedars-Sinai.


“I am excited to expand clinical trials in thoracic medical oncology within the greater Los Angeles area and the growing Cedars-Sinai Cancer network so that patients with thoracic malignancies, including lung cancer, lung neuroendocrine tumors, thymic malignancies and malignant mesothelioma, have access to these novel therapies," shares Dr. Padda.
"I also very much look forward to working with the scientists at Cedars-Sinai Cancer on translational work, including novel targets and biomarkers- all with the ultimate goal to improve the care of patients with thoracic malignancies." Click here to read more about Dr. Padda's transition.